Winter 2024
By Lucy McDonald
Photography by Sam Ogden
AstraZeneca awarded over $360,000 to Dana-Farber to appoint a patient navigator to expand equitable access to clinical trials within the Breast Oncology Research Program. This navigator will proactively engage with patients with breast cancer and will focus on outreach and education to patients from historically marginalized communities to help navigate clinical trial complexities, logistics, and resources.